🇺🇸 FDA
Patent

US 7241860

Transcription factor polypeptide that regulates Chondromodulin-I expression

granted A61KA61K38/00A61P

Quick answer

US patent 7241860 (Transcription factor polypeptide that regulates Chondromodulin-I expression) held by Takeda Pharmaceutical Company Limited expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61P, A61P19/00, A61P19/02